Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew E Harinstein

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|October 2, 2012
Role of baseline echocardiography in the preoperative management of liver transplant candidatesMatthew E Harinstein, Sunil Iyer, Michael A Mathier, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Assessment and management of coronary artery disease in kidney and pancreas transplant candidatesJoseph T Knapper, Zankhana Raval, Matthew E Harinstein, et al.
Heart Failure Reviews|February 25, 2009
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?Hashim Khan, Marco Metra, John E A Blair, et al.
Heart Failure Clinics|July 2, 2013
The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failureNorman C Wang, Jonathan P Piccini, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|July 9, 2011
Cardiovascular risk assessment of the liver transplant candidateZankhana Raval, Matthew E Harinstein, Anton I Skaro, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 27, 2019
Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant CandidatesJayson Rakesh Baman, Joseph Knapper, Zankhana Raval, et al.
American Journal of Therapeutics|May 23, 2008
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trialJohn E A Blair, Cezar Macarie, Witold Ruzyllo, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 9, 2016
Right Ventricular Function and Prognosis in Patients with Low-Flow, Low-Gradient Severe Aortic StenosisJoão L Cavalcante, Shasank Rijal, Andrew D Althouse, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 26, 2011
Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experienceAoife N Keeling, James D Flaherty, Amir H Davarpanah, et al.
Plos One|February 8, 2021
SafeNET: Initial development and validation of a real-time tool for predicting mortality risk at the time of hospital transfer to a higher level of careStefanie C Altieri Dunn, Johanna E Bellon, Andrew Bilderback, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|October 2, 2012
Role of baseline echocardiography in the preoperative management of liver transplant candidatesMatthew E Harinstein, Sunil Iyer, Michael A Mathier, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Assessment and management of coronary artery disease in kidney and pancreas transplant candidatesJoseph T Knapper, Zankhana Raval, Matthew E Harinstein, et al.
Heart Failure Reviews|February 25, 2009
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?Hashim Khan, Marco Metra, John E A Blair, et al.
Heart Failure Clinics|July 2, 2013
The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failureNorman C Wang, Jonathan P Piccini, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|July 9, 2011
Cardiovascular risk assessment of the liver transplant candidateZankhana Raval, Matthew E Harinstein, Anton I Skaro, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 27, 2019
Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant CandidatesJayson Rakesh Baman, Joseph Knapper, Zankhana Raval, et al.
American Journal of Therapeutics|May 23, 2008
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trialJohn E A Blair, Cezar Macarie, Witold Ruzyllo, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 9, 2016
Right Ventricular Function and Prognosis in Patients with Low-Flow, Low-Gradient Severe Aortic StenosisJoão L Cavalcante, Shasank Rijal, Andrew D Althouse, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 26, 2011
Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experienceAoife N Keeling, James D Flaherty, Amir H Davarpanah, et al.
Plos One|February 8, 2021
SafeNET: Initial development and validation of a real-time tool for predicting mortality risk at the time of hospital transfer to a higher level of careStefanie C Altieri Dunn, Johanna E Bellon, Andrew Bilderback, et al.
Pageof 6